Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

TETRAGENETICS, INC

TETRAGENETICS, INC is a federal contractor, registered under UEI E4V5EMGNKBY5. It has been awarded $4,707,271 in federal contracts. Primary work spans Unknown NAICS, Research and Development in the Physical, Engineering, and Life Sciences, and Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). Top awarding agencies include Department Of Health And Human Services, Department Of Energy, and Department Of Defense.

Contact Information

Registration and classification details

Registration

UEI Code

E4V5EMGNKBY5

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

TetraGenetics, Inc. specializes in advanced biotechnology and protein engineering, with a primary focus on the development of innovative protein expression platforms. The company possesses deep technical expertise in utilizing Tetrahymena for the overexpression and rapid purification of membrane and...

TetraGenetics, Inc. specializes in advanced biotechnology and protein engineering, with a primary focus on the development of innovative protein expression platforms. The company possesses deep technical expertise in utilizing Tetrahymena for the overexpression and rapid purification of membrane and secretory proteins. Their capabilities extend to the discovery of KCA3.1-inhibiting antibodies for asthma treatment and the development of novel methods for high-level expression of aglycosylated and fully glycosylated proteins. They provide specialized services in biological product manufacturing and the creation of innovative protein production technologies across microbes and plants. The company maintains a strong track record of supporting the Department of Defense, the Department of Health and Human Services, and the Department of Energy. Their work for these agencies spans basic scientific research services, the development of biological materials, and the advancement of genomes-to-life biotechnologies. Their industry focus is centered on biological product manufacturing and research and development within the physical, engineering, and life sciences. In practice, this involves a vertical specialization in biotechnology, specifically targeting the intersection of genetic research and the scalable production of complex proteins.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

11

All time

Active

0

Currently performing

Completed

11

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with TETRAGENETICS, INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for TETRAGENETICS, INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in TETRAGENETICS, INC's top NAICS codes and agencies

NAICS: 541712
New
DIBBS
CLAMP, LUBRICATION, A
Solicitation # SPE7M4-27-T-2790
The DLA Weapons Support Fluid Handling Division is soliciting the procurement of 43 units of Lubrication Clamp A, identified as NSN 1710-01-478-1533. This item is designated as a critical application item, with specific part numbers associated with Safran Landing Systems Canada Inc and The Boeing Company. The contract specifies a delivery timeframe of 168 days after award, with a need ship date of May 4, 2027, and an original required delivery date of February 18, 2028. Shipping is established as FOB Origin, with the final destination, inspection, and acceptance point located at DLA Distribution San Diego. Quality and technical requirements are stringent, requiring the manufacturer's inspection system to comply with ISO 9001:2015 or an equivalent standard. Sampling must follow MIL-STD-1916, ASQ H1331, or a comparable zero-based sampling plan, with acceptance requiring zero non-conformances under MIL-STD-105/ASQ Z1.4. Packaging must adhere to ASTM D3951 and RP001, while all marking and labeling must comply with MIL-STD-129. The contract incorporates various FAR and DFARS clauses, including mandates for safeguarding covered defense information, prohibitions on hexavalent chromium and certain telecommunications equipment, and adherence to the Buy American and Balance of Payments Program. Payment and invoicing are to be processed electronically via Wide Area WorkFlow.
DLA WEAPONS SUPPORT FLUID HANDLING DIVISION

POSTED

3 days ago

DEADLINE

in 7 days
View Details
NAICS: 325414
New
International
Реагенти для лабораторії імуногенетичних технологій та біоінженерії – ДК 021:2015 – 33690000-3 - Лікарські засоби різні (КЛІТИННА ЛІНІЯ Nalm-6-Zellen – Код ДК 021:2015 – 33696500-0 - Лабораторні реактиви (НК 024:2023/НК 031:2024 – 30670 - Лінія клітинної
Solicitation # UA-2026-11-06-013516-a
The National Children's Specialized Hospital Okhmatdyt of the Ministry of Health of Ukraine is soliciting bids for the procurement of laboratory reagents, specifically the Nalm-6 cell line, for the Laboratory of Immunogenetic Technologies and Bioengineering. This solicitation, identified by number UA-2026-11-06-013516-a, is categorized under various medical and laboratory reagent codes. The performance of the contract and delivery of goods will take place in Kyiv, Ukraine. Interested parties must submit their responses by the deadline of November 22, 2026. A critical compliance requirement for this contract is that the goods provided cannot originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. Primary contact for this procurement is Maryna Yakymchuk.
Державне некомерційне підприємство «Національна дитяча спеціалізована лікарня «Охматдит» МОЗ України»

POSTED

3 days ago

DEADLINE

in 14 days
View Details
NAICS: 541618
New
OTA
Rapid Facility Clearance Cohort Pilot: Enabling Classified Technology Assessment and Bi-Directional Collaboration for Joint Operational Problems and Mission Capabilities Priorities
Solicitation # 8ee1fe86-14b2-42dd-974d-14259bd579e8
The Office of the Under Secretary of War for Research and Engineering, in coordination with the Defense Innovation Unit and Mission Engineering and Integration Activity, is establishing a Rapid Facility Clearance Mentorship and Prototyping Cohort. This pilot program addresses the procedural barrier where non-traditional, small-business, and commercial providers cannot access classified work without a Facility Clearance, yet cannot obtain one without a classified contract. Through subcontract relationships with Maximus Federal Services under the ONIX OTA framework, selected participants receive security mentorship and sponsorship for Facility Clearances adjudicated by the Defense Counterintelligence and Security Agency. The primary objective is to allow the government to assess emerging technologies and conduct collaborative dialogue in classified settings to reduce transition risk and accelerate Joint Force capabilities. Participation in the cohort provides a security pathway and potential access to classified technical exchanges but does not guarantee funded technical work, the acquisition of products, or preferential status. Vendors are not paid for participating in the cohort or the sponsorship process and are responsible for all administrative and compliance costs associated with maintaining industrial security programs.
Department Of Defense

POSTED

3 days ago

DEADLINE

in 5 months
View Details
NAICS: 325414
New
DIBBS
MEDICAL PHARMACY EMERGENCY NON NSN ORDER
Solicitation # SPE2DP-26-R-0004
Solicitation SPE2DP-26-R-0004 is a Request for Proposal issued on November 4, 2026, by the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of egg-free Influenza Virus Vaccine, 2027-2028 Formula for adults aged 18 and older. The government intends to award a Firm Fixed Price, Indefinite Delivery, Indefinite Quantity contract to the responsible offeror determined to be most advantageous based on price and non-price factors. Proposals must be submitted electronically via the DIBBS system by December 3, 2026. Award criteria include the proposed unit and total price, agreement to all solicitation terms without exception, and, for large businesses, the submission of a Small Business Subcontracting Plan. The contract mandates strict quality and cold chain management standards, requiring vaccines to be maintained between 2 to 8 degrees Celsius during transportation for up to 72 hours with no acceptable excursions. Products must be delivered to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, and must have an expiration date no later than 18 months after the date of issue from the manufacturer's cold storage. Manufacturers must be FDA current Good Manufacturing Practice acceptable. Packaging and marking must adhere to Medical Marking Standard No. 1D and MIL-STD-129 for perishables. Invoicing and payment will be processed electronically through the Wide Area Workflow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

5 days ago

DEADLINE

in 24 days
View Details